Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Company News

X-Chem, Vertex drug discovery deal

June 2, 2017 7:19 PM UTC

X-Chem Inc. (Waltham, Mass.) will use its X-Chem's DEX library to discover small molecules against undisclosed targets implicated in severe genetic diseases. Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) has exclusive options to license and develop compounds discovered under the deal, which may be expanded to include additional targets...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article